Lawsuit filed against RFK Jr over vaccine policy changes; oral on-demand treatment approved for HAE; OTC cuffless blood pressure monitor gets greenlit; ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Unfortunately, Dr Monarez, who has served as Trump’s acting CDC director, has done nothing to stand in the way” of Kennedy’s actions, said Sen. Bernie Sanders.

TRUE or FALSE. Enflonsia (clesrovimab-cfor) is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering ...

HealthDay News — The US Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

An Associated Press investigation found that many of Mom’s Meals' offerings are highly processed and contain ingredients that wouldn’t be found in a home kitchen.

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

HealthDay News — The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.